Jet Protocol Lists on AscendEX

Singapore, Oct. 08, 2021 (GLOBE NEWSWIRE) — AscendEX is thrilled to announce the listing of the Jet Protocol token (JET) under the trading pair JET/USDT on Oct. 14 at 1 p.m. UTC. To celebrate the listing of JET, AscendEX will host two separate auctions that will take place simultaneously on October 13 between 1 p.m. and 2 p.m. UTC.

Jet Protocol will be launched as an open–source, non–custodial, borrowing and lending protocol on the Solana Blockchain. It engineers new possibilities for capital efficiency, performance, and scalability. Jet allows users to participate in lending pools where they deposit supported tokens to receive interest, or "yield" over time, as a participation incentive. Those deposits remain in a pool used for issuing loans to other users for as long as the assets remain delegated.

Jet believes that borrowing and lending protocols are integral to the DeFi ecosystem. The decision to build on Solana was based on its unmatched transaction speed and low fees. The Solana integration will allow Jet to contribute and grow on–chain DeFi lending. The project anticipates a gradual integration of broader interest and more efficient trading. In addition to lending, Jet will introduce interest rate products and secondary markets on Serum, facilitating ongoing, community–driven, lending product research and development. Through these methods, Jet makes it easy for users to earn interest with their JET tokens.

Jet is planning to launch with a dedicated governance system that leverages their founding team's unique and extensive experience in protocol governance. This governance–oriented approach aims to work with the community to set a clear precedent toward how the Protocol will operate. Jet will innovate on tested governance models from existing protocols while focusing on community ownership and engagement. The most important aspect of this approach is to build an inclusive community to research, design, and implement useful lending products. So, the token holders will have a say in the future of the platform. This focus on community is core to Jet's mission of bringing DeFi protocols into the mainstream.

Prior to a successful mainnet launch this week, Jet recently completed a follow–on funding round that included AscendEX among other partners bringing in a total of $6.8mm to the project. This latest fundraise has highlighted the strong support for Jet from a variety of stakeholders including AscendEX.

About AscendEX
AscendEX is a global cryptocurrency financial platform with a comprehensive product suite including spot, margin, and futures trading, wallet services, and staking support for over 200 blockchain projects such as bitcoin, ether, and ripple. Launched in 2018, AscendEX services over 1 million retail and institutional clients globally with a highly liquid trading platform and secure custody solutions.

AscendEX has emerged as a leading platform by ROI on its "initial exchange offerings" by supporting some of the industry's most innovative projects from the DeFi ecosystem such as Thorchain, xDai Stake, and Serum. AscendEX users receive exclusive access to token airdrops and the ability to purchase tokens at the earliest possible stage. To learn more about how AscendEX is leveraging best practices from both Wall Street and the cryptocurrency ecosystem to bring the best altcoins to its users, please visit

For more information and updates, please visit:

About Jet Protocol
Jet Protocol will launch as an open–source, non–custodial borrowing and lending Protocol on the Solana Blockchain. Jet re–engineers what's possible in terms of capital efficiency, performance, and scalability on Solana. The Protocol allows users to participate in lending protocols where they deposit supported tokens to the platform and then receive interest on their deposits to incentivize participation.

For more information and updates, please visit:


Mounting Scramble for Coronavirus Vaccines in Zimbabwe

Zimbabweans readily join the COVID-19 vaccine queues, but the rollout hasn’t been smooth. Credit: Jeffrey Moyo/IPS

By Jeffrey Moyo
HARARE, Zimbabwe , Oct 8 2021 – More than a month ago, she lost her parents, brother, and wife, to the coronavirus. Then her fiancé battled COVID-19, but 27-year-old Melinda Gavi said she had not contracted the disease.

Gavi joined crowds scrambling to get vaccinated at Parirenyatwa hospital in the Zimbabwean capital Harare even though she was previously sceptical about getting vaccinated against the dreaded disease.

Her parents, brother, and wife were equally sceptical of the COVID-19 vaccines before they were visited by the disease, which eventually claimed their lives.

In a country of about 15 million people, nearly 5.5 million have had at least had one dose of the vaccine the Reuters COVID-19 tracker, which assuming that each person needs two doses, represents 18.8% of the population.

The World Health Organisation (WHO) confirmed in October that Zimbabwe had received 943 200 COVID-19 vaccine doses from the global COVAX Facility in September and October for its ongoing vaccination campaign.

IPS has been following the rollout of the vaccines in various centres over the past few months, recording people’s personal experiences in the queues.

Gavi says it has taken her days to get vaccinated.

“This is my third day coming here at Parirenyatwa to try and get vaccinated,” Gavi told IPS as she stood in a long and meandering queue at Zimbabwe’s biggest hospital.

About 200 people gathered at the back of the hospital, some looking tired as they lingered in the queue. Some sat on the pavements and or flower beds, waiting for their turn to get vaccinated in the slow-moving queue.

“We have limited vaccines, and often on a day we are vaccinating just 80 people and everybody else often just goes back home without getting vaccinated,” a nurse who refused to be named as she was unauthorised to speak to the media, told IPS.

In February this year, Zimbabwe began vaccinating its citizens against coronavirus after receiving a donation of 200 000 doses of China’s Sinopharm vaccine.

But when the vaccine first arrived, it was met with growing scepticism from social media platforms like WhatsApp, Twitter, and Facebook, which fuelled the vaccine hesitancy.

This is no longer the case. Now healthcare workers have to battle hordes of people scrambling for the vaccine.

“With time, as more and more people got vaccinated without severe safety fears, the public became more assured, and demand for vaccines gradually started to rise,” said epidemiologist Dr Grant Murewanhema in Harare.

In Bulawayo, on July 8, in the presence of IPS, at the United Bulawayo Hospital, a nurse moved along the queue of people waiting to get vaccinated, counting up to 60 recipients. She told the rest to return the next day.

She told them she only had enough vaccines for 60 people.

At number 60 was 47-year-old Jimmy Dzingai, who said he was a truck driver.

“Oh, better, at least I am going to get vaccinated,” said Dzingai then as he heaved a sigh of relief, folding his hands across his chest.

Meanwhile, as they were told to leave, others did so but grumbled as they filed outside the hospital, some waving their face masks in anger, shouting at hospital authorities for turning them away.

“This is not the first time I am coming here to try and get vaccinated. I have been here four times, and this is my fifth day starting mid-June – only to get excuses,” 54-year-old Limukani Dlela, a man who said he lived in Matsheumhlope, a low-density suburb in Bulawayo, told IPS saying that at times the excuse was that there not enough vaccines available and at other times there were a limited number of vaccines.

Corruption and nepotism have characterised this Southern African country’s bitter war against COVID-19, and many people like Dzingai, the truck driver, have not been spared by the rot.

As Dzingai stood at the end of the queue, four middle-aged women strode past him and all others, going straight to the head of the queue and quickly got vaccinated and left.

According to one of the nurses who manned the queue, “the four were staff members and couldn’t wait in the queue like everybody else.”

The nurse said this even though the four women, after receiving doses, immediately left the premises just like any other ordinary person.

“I was talking to my bosses right now, and my truck has been loaded for me to take the delivery to Zambia. I have told my bosses I was getting my vaccine. Instead, you are telling me I’m not going to be vaccinated. You should get water to inject me and give me the vaccine certificate. I will not leave this place without the vaccine,” swore the truck driver.

But the nurse would have none of it.

“You won’t be vaccinated today. That won’t happen, unfortunately,” she said.

Dzingai vowed to stay put at the hospital until he was vaccinated, but because the four women who jumped the queue and got vaccinated before him, it meant he (Dzingai) and three others who had waited at the end of the queue had to leave without the jab.

With many Zimbabweans like Dzingai now eager to get vaccinated, the government has so far authorised the use of China’s Sinovac and Sinopharm, Russia’s Sputnik V, and India’s Covaxin and the U.S. Johnson and Johnson vaccines.

It has not, however, been easy for people to get the doses. Now bribery has become the order of the day at Zimbabwe’s hospitals like Sally Mugabe Referral hospital in the capital Harare.

Lydia Gono (24), from Southertorn middle-income suburb in Harare, said she had to ‘switch to her purse’, which is local parlance for a bribe, to get quickly vaccinated at Sally Mugabe hospital, the closest medical facility to her home.

“I spent close to a week trying to get vaccinated here without success, but today I just rolled a US 10 dollar note in my hand and shook the hand of a nurse who manned the queue, leaving the note in her hand. I was taken to the front and vaccinated without any delay,” Gono told IPS.

Tired of the corruption and nepotism and the delaying tactics characterising the vaccination process at public healthcare centres, many middle-income earners like 35-year-old Daiton Sununguro have opted for the private medical centres to get their vaccines parting with US 40 dollars for a single dose.

“Paying is better than having to wait for many hours before getting the vaccine at public healthcare facilities. I will still come back and pay the other US 40 dollars for my second dose,” Sununguro told IPS at a posh private medical facility in Harare’s Mount Pleasant low-density suburb.


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);;js.src=p+’://’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);